XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Reporting - Schedule of Segment Revenue and Operating Income (Details)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
segment
Sep. 30, 2021
USD ($)
Segment Reporting [Abstract]          
Number of operating segments | segment       2  
Segment Reporting Information [Line Items]          
Revenues   $ 620.6 $ 559.2 $ 1,832.2 $ 1,614.9
Adjusted EBITDA   96.2 76.4 259.4 225.2
Reconciliation of Adjusted EBITDA:          
Income before income taxes   13.4 9.4 77.1 26.5
Net income attributable to non-controlling interests   (30.6) (31.1) (94.9) (98.6)
Depreciation and amortization   29.8 25.2 85.2 76.1
Interest expense, net   60.7 54.2 173.9 160.9
Equity-based compensation expense   5.0 4.1 13.0 13.4
Transaction, integration and acquisition costs   13.1 10.2 28.4 31.0
Loss on disposals and deconsolidations, net   2.2 1.9 3.2 2.0
Loss (gain) on litigation settlement and other litigation costs   1.5 2.5 (27.6) 4.3
Loss on debt extinguishment   0.0 (0.5) 0.0 9.1
Hurricane-related impacts   1.1 0.5 1.1 0.5
Adjusted EBITDA   96.2 76.4 259.4 225.2
Transaction and integration costs   12.5 10.2 27.8 24.7
Start-up costs   0.6   0.6 6.3
Other litigation costs   1.5 2.5 5.2 4.3
Litigation settlement $ 32.8 0.0 0.0 32.8 0.0
Operating Segments | Surgical Facility Services          
Segment Reporting Information [Line Items]          
Revenues   603.9 542.1 1,780.6 1,563.7
Adjusted EBITDA   110.2 96.9 319.9 287.5
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   110.2 96.9 319.9 287.5
Operating Segments | Ancillary Services          
Segment Reporting Information [Line Items]          
Revenues   16.7 17.1 51.6 51.2
Adjusted EBITDA   (1.5) 0.0 (2.2) (1.0)
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   (1.5) 0.0 (2.2) (1.0)
All other          
Segment Reporting Information [Line Items]          
Adjusted EBITDA   (12.5) (20.5) (58.3) (61.3)
Reconciliation of Adjusted EBITDA:          
Adjusted EBITDA   $ (12.5) $ (20.5) $ (58.3) $ (61.3)